US0375981091 - Common Stock
APOG stock results show that Apogee Enterprises beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Investors are more bullish about small and mid-cap biotech stocks this year, with Merus (MRUS) and Fusion (FUSN) viewed as most likely to outperform, according to TD Cowen.
Apogee Enterprises announces strategic cost-cutting measures in its architectural framing systems segment, including job reductions and simplified...
Apogee (APOG) declares $0.25/share quarterly dividend, 4.2% increase from prior dividend of $0.24. Forward yield 1.89% Payable Feb. 14; for shareholders of reco
APOG stock results show that Apogee Enterprises beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apogee Enterprises (NASDAQ:APOG) just reported results for the third quarter of...
Apogee reported Q3 Non-GAAP EPS of $1.23, beating expectations by $0.12. However, revenue of $340M missed expectations by $20.04M.
These three construction stocks have been resilient despite the market environment, and we think you should pick them up now.
Apogee Enterprises increases share repurchase program by 2M shares and declares a quarterly dividend of $0.24.
Apogee press release (APOG): Q2 Non-GAAP EPS of $1.36 beats by $0.22.Revenue of $354M (-5% Y/Y) misses by $16.35M.Increasing full-year adjusted diluted EPS outlook to a range of...